JOHNSON & JOHNSON
Recent Filings
All 1,004 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| MORIKIS JOHN G | — | Purchase | 1,250 @ $206.15 | 1,849 | Nov 26, 2025 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 21,721 @ $192.71 | 10,658 | Oct 17, 2025 |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sale | 56,471 @ $177.81 | 178,013 | Sep 4, 2025 |
| Duato Joaquin | CEO and Chairman of the Board | Sale | 125,824 @ $179.21 | 275,967 | Aug 22, 2025 |
| REED JOHN C | EVP, Innovative Medicine, R&D | Sale | 19,137 @ $163.55 | 10,658 | Jul 17, 2025 |
| Decker Robert J | VP Corporate Controller | Sale | 6,999 @ $165.88 | 21,001 | Feb 25, 2025 |
| WEINBERGER MARK A | — | Purchase | 1,000 @ $147.22 | 1,000 | Dec 12, 2024 |
| Decker Robert J | VP Corporate Controller | Sale | 5,635 @ $165.06 | 18,973 | Aug 30, 2024 |
| Woods Eugene A. | — | Purchase | 100 @ $145.53 | 250 | Apr 30, 2024 |
| Broadhurst Vanessa | EVP, Global Corp Affairs | Sale | 8,891 @ $162.16 | 15,043 | Mar 13, 2024 |